Prognostic markers in acute liver injury
What it is
A sudden increase in serum AST and ALT levels is acute liver injury. Acute liver failure is acute liver injury complicated by encephalopathy and coagulopathy, with an INR >1.5, in a patient without previous cirrhosis. The two markers that carry the word failure are therefore not the transaminases but the encephalopathy and the INR.
Causes and risk
The most common identifiable causes of acute liver injury are acetaminophen hepatotoxicity, idiosyncratic drug reactions and HBV infection.
How it is diagnosed
The first step is to determine a hepatocellular from a cholestatic picture, and the tests separate into groups by what they mark:
- Markers of hepatocytolysis or apoptosis: the transaminases, ALT and AST.
- Markers of a cholestasis or infiltrative process: the cholestatic enzymes, ALP and GGT.
- Markers of the biliary excretion process: T Bili and D Bili.
- Markers of synthetic or metabolic capacity: INR, albumin and conjugated bilirubin.
Only the last group measures what the liver can still do: INR, bilirubin and albumin are impaired in acute fulminant failure or in advanced chronic liver disease. The others are neither specific to the liver nor true measures of liver function.
Two points about the transaminases follow from that. ALT is a specific and sensitive indicator of hepatocellular injury, and an increased ALT almost always indicates liver injury. AST is found in many tissues, including liver, heart, skeletal muscle, brain, kidney, pancreas and RBC, so an isolated high AST is not always of liver origin. An AST greater than ALT with a ratio of 2 to 3 is seen in cirrhosis, acute alcoholic hepatitis or Wilson.